Evaluation of a Contribution of Biochemical, Immunogenetic and Morphofunctional Indices to the Development and Severity of the Course of Chronic Obstructive Pulmonary Disease Combined with Arterial Hypertension Using One-Way ANOVA Test


chronic obstructive pulmonary disease (COPD)
arterial hypertension (AH)
correlation and one-way ANOVA test methods

How to Cite

Cherniuk, N. V. (2014). Evaluation of a Contribution of Biochemical, Immunogenetic and Morphofunctional Indices to the Development and Severity of the Course of Chronic Obstructive Pulmonary Disease Combined with Arterial Hypertension Using One-Way ANOVA Test. Galician Medical Journal, 21(2), 1-4. Retrieved from https://ifnmujournal.com/gmj/article/view/362


The aim of the investigation is to trace the connections between etiological factors, metabolic pathogenesis of chronic obstructive pulmonary disease (COPD), combined with arterial hypertension (AH). Material and methods. The study involved 184 patients with a combination of COPD and hypertension of the  second degree, stage II, 180 patients with COPD and 40 apparently healthy age-appropriate  individuals. Cytogenetic method was used to determine the ontogenetic features of the hereditary apparatus of 78 individuals.  The findings of 38 clinical, instrumental, biochemical, immunogenetic and morphometric markers were analyzed by means of correlation and one-way ANOVA test methods. Results. 186 mean force correlations were registered between the indices of spirogram, genetic markers, cytokine profile characteristics, endogenous intoxication, peroxidation of proteins and lipids, antioxidant defense system, cellular composition of bronchoalveolar lavage (BAL). The involvement of genetic background in health promotion of the investigated sample made up 21.5 %. The use of one-way ANOVA test made it possible to reveal five groups of clinical, immunocytogenetic, molecular and morphometric markers, according to which all stages of COPD associated with AH have significant differences. Conclusions. Significant correlations have been estimated between the indices of structural and functional status of genotype in patients with COPD and AH. The investigation proved essential changes of chromosomes and epigenetic chromatin modifications in somatic cell nuclei, concentration of IL-22 in patients with comorbide pathology as compared to those with COPD that was accompanied by significant impairment of endogenous intoxication level, decrease in normal and increase in pathological epithelial cells and neutrophils in BAL


Feshchenko Yu.I. New edition of global initiative for COPD. Ukrainskyi pulmonolohichnyi zhurnal. 2012; 2: 6-8.

Habor M.L., Kazankevych V.P., Reshetar D.V., Zadorozhna T.O. Lipid peroxidation and the state of antioxidant defense in patients with chronic obstructive pulmonary disease with secondary immunodeficiency. Naukovyi visnyk Uzhhorodskoho universytetu, series “Medytsyna”. 2007; 30: 33-36.

Khan F., Sherwani A. F., Afzal M. Chromosomal aberration and micronucleus studies of two topoisomerase (II) targeting anthracyclines. Journal of Environmental Biology. 2009; 30(3): 409-412.

Kovaliova O.A. Cytogenetic anomalies in somatic cells of mammals.Tsytolohiia i genetyka. 2008;1: 58-62.

Kutsenko L.A., Kaidashov I.P. The place of ceruloplasmin among acute phase proteins as a marker of systemic inflammation. Laboratornaia diahnostyka. 2011; (57): 59-68.

Ley K., Smith E., Stark M. IL-17A-producing neutrophil-regulatory Th lymphocytes. Immunol. Res. 2006; 34(3): 229-242.

Ostrovskyi M.M. Broncho-obstructive syndrome: issues of diagnosis and treatment. Ukrainskyi pulmonolohichnyi zhurnal. 2011; 2: 14-16.

Pertseva T.O., Panina S.S., Kontsur V.M. Medical-and-social aspects of disability in chronic obstructive bronchitis. Ukrainskyi pulmonolohichnyi zhurnal. 2011; 4: 12-15.

Rahman J., Biswas S. K., Kode A. Oxidant and antioxidant balance in the airways and airways diseases. Eur. J. Pharmacol. 2006; 533: 222-239.

Rasputina L.V. Characteristics of endothelium-dependent vasodilation and structural-and-functional cardiac remodeling in patients with combined course of chronic obstructive pulmonary disease and hypertension. Ukrainskyi pulmonolohichnyi zhurnal. 2012; 2: 55-58.

Rekalova Ye.M. Panasiukova O.R., Kadan L.P. et al. Clinical-and-immunological characteristics of different phenotypes of chronic obstructive pulmonary disease. Ukrainskyi pulmonolohichnyi zhurnal. 2011; 3: 34-37.

Zadiochenko V.S., Adasheva T.V., Fedorova I.V. et al. Arterial hypertension and chronic obstructive pulmonary disease: pathogenetic parallels and clinical-and-functional characteristics. Kardio Somatika. 2010; 1: 1-9.

Sabia S., Shipley M., Elbaz A., Marmot M. [et al.] Why Does Lung Function Predict Mortality? Results From the Whitehall II Cohort Study. Am. J. Epidemiol. 2010; 172 (12): 1415-1423.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.